[ad_1] GE Healthcare ‘s quiet outperformance is becoming harder to tune out — and its new…
Tag: Eli Lilly and Co
FTC sues drug middlemen for allegedly inflating insulin prices
[ad_1] Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee…
Why Eli Lilly and Palo Alto Networks are both up on news from their competitors
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
[ad_1] The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to…
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
[ad_1] Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer…
Eli Lilly says it will invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer’s drugs
[ad_1] A sign with the company logo sits outside of the headquarters of Eli Lilly in…
We’re taking a nearly 300% profit on a hot drug stock — adhering to an investing rule to live by
[ad_1] Shortly after the opening bell, we’ll be selling 10 shares of Eli Lilly at roughly…
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
[ad_1] Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for…
Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial
[ad_1] Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes…